| 000 | 01591 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518081100.0 | ||
| 264 | 0 | _c20200218 | |
| 008 | 202002s 0 0 rus d | ||
| 022 | _a1997-7298 | ||
| 024 | 7 |
_a10.17116/jnevro2019119102110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEvdoshenko, E P | |
| 245 | 0 | 0 |
_a[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]. _h[electronic resource] |
| 260 |
_bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _c2019 |
||
| 300 |
_a110-119 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAzetidines _xadverse effects |
| 650 | 0 | 4 |
_aBenzyl Compounds _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Chronic Progressive _xdrug therapy |
| 650 | 0 | 4 | _aRussia |
| 700 | 1 | _aNeofidov, N A | |
| 700 | 1 | _aBakhtiyarova, K Z | |
| 700 | 1 | _aDavydovskaya, M V | |
| 700 | 1 | _aKairbekova, E I | |
| 700 | 1 | _aKolontareva, Yu M | |
| 700 | 1 | _aMalkova, N A | |
| 700 | 1 | _aOdinak, M M | |
| 700 | 1 | _aPopova, E V | |
| 700 | 1 | _aSazonov, D V | |
| 700 | 1 | _aStolyarov, I D | |
| 700 | 1 | _aSmagina, I V | |
| 700 | 1 | _aFedyanin, A S | |
| 700 | 1 | _aHabirov, F A | |
| 700 | 1 | _aKhaibullin, T I | |
| 700 | 1 | _aKhachanova, N V | |
| 700 | 1 | _aShchukin, I A | |
| 700 | 1 | _aBoyko, A N | |
| 773 | 0 |
_tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _gvol. 119 _gno. 10. Vyp. 2 _gp. 110-119 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.17116/jnevro2019119102110 _zAvailable from publisher's website |
| 999 |
_c30515939 _d30515939 |
||